at Nasdaq.com (Tue, 2:51PM)
Merck's (MRK) Zolinza drug for a rare form of cancer may also one day be used to help cure AIDS. While existing treatments hold the disease at bay, they don't kill HIV-infected cells, which can remain hidden and then later re-emerge if treatment is stopped. However, Zolinza reactivated those cells in eight patients - the first step to expelling the virus from the body.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Nasdaq.com (Mon, 12:38PM)
at Zacks.com (Jan 16, 2015)
at Zacks.com (Jan 15, 2015)
at Nasdaq.com (Jan 15, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs